HBK Sorce Advisory »

Neumora Therapeutics shares owned by HBK Sorce Advisory

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by HBK Sorce Advisory from 13F filings

Historical chart of HBK Sorce Advisory investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by HBK Sorce Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by HBK Sorce Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $31k 17k 1.84
2025-06-30 $12k 16k 0.73

More positions owned by HBK Sorce Advisory

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Large Cap Vec (DFVX)
Apple (AAPL)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Core Fixed Incom (DFCF)
NVIDIA Corporation (NVDA)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for HBK Sorce Advisory

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Siren
Vanguard Group
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
ICONIQ Capital
Lunate Capital
Millennium Management
T. Rowe Price Investment Management
Johnson & Johnson
BlackRock
Tang Capital Management
Renaissance Technologies
Two Sigma Advisers

View all funds holding Neumora Therapeutics